PF-06827443
PF-06827443 is a potent, low-clearance, orally bioavailable, and CNS-penetrant M1-selective positive allosteric modulator (PAM) with minimal agonist activity. PF-06827443 induce cholinergic AEs and convulsion[1].
Product Specifications
CAS Number
2115022-67-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pf-06827443.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CC3=CC=C(C4=COC=N4)C=C3)=C(C)C=C2CN1[C@@H]5[C@H](COCC5)O
Molecular Formula
C24H24N2O4
Molecular Weight
404.46
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Jennifer E Davoren, et, al. Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs) : Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. J Med Chem. 2017, 60, 15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1864-50 1x 50 µL
AMACR / p504S (Prostate Cancer Marker) (AMACR/1864), 1mg/mL
Sign In for Pricing
View Details ![MED30 Mouse Monoclonal Antibody [Clone ID: OTI3B3]](https://cdn.genprice.uk/products/937/68dd18b9061270361e90822c/imageurl/cf808041.webp)